Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Bevacizumab

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCNEU15105

    07/15/2016

    A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma


    Print this page for your doctor